In myeloid malignancies, ID1 and ID2 were lowly expressed in acute promyelocytic leukemia (APL) cells (NB4) and were rapidly induced upon all-trans retinoic acid (ATRA) treatment [10]. This evidence concerns the gene ID1 and acute promyelocytic leukemia.